Global data pooling aims to unlock secrets of rare muscle disease
NCT ID NCT07443449
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study brings together patient registries from 10 countries to analyze data from 700 people with spinal and bulbar muscular atrophy (SBMA). Researchers will look at changes in muscle function, walking ability, and age of symptom onset. The goal is to better understand how the disease progresses over time, which could help guide future research and care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a better understanding of how SBMA progresses over time, helping design future treatments.
- What could go wrong
- This is a retrospective observational study, not a treatment trial. It cannot test new therapies, and results may be limited by differences in how data was collected across countries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SBMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, 20133, Italy